Genzyme Transgenics

Genzyme Transgenics Corporation is a leader in the production of therapeutic proteins in the milk of transgenic animals. Transgenic animals carry specific genetic material that allows them to produce human proteins in their milk. Unique molecular biology and production expertise has enabled Genzyme Transgenics to produce more than 60 therapeutic proteins, including monoclonal antibodies, plasma proteins and certain hard-to-express proteins in the milk of mice, rabbits, goats and cows.

Genzyme Transgenics' production efforts are focused on the development of proteins for commercial use. Particularly, the company has developed substantial expertise and increasing focus on monoclonal antibodies for therapeutic use in chronic diseases such as rheumatoid arthritis, other autoimmune conditions and cancer. To this end, the Company actively seeks partnerships with pharmaceutical and other biotechnology companies to develop drug candidate proteins transgenically in exchange for revenues and royalties. Genzyme Transgenics may also use transgenic technology to develop novel proteins and seek to commercialize these proteins through collaborative agreements with corporate partners.